New Canadian paper below warns that shingles may spuriously affect PSA.
***
I caught chickenpox 45 years ago from my daughter & really should get a shingles vaccine shot.
My wife, who did get the shot has since had 2 attacks. Tomorrow will be 3 years since her doctor called an ambulance to take her to the ER because of vagus nerve pain (everyone panics when there is chest pain). ER eventually lost interest when they couldn't find a clot, but couldn't release her because she was incapacitated by pain. She spent 3 nights & days in the cancer ward (she was under treatment for a plasmacytoma) before the right mix of drugs was found to manage the pain.
Her oncologist said that more than half of his multiple myeloma cases experience shingles - in one case, for 9 months. My wife was loaded up with the antiviral Aciclovir & continues to be on an antiviral.
The weeks went by without good pain control. My son had insisted that astragalus might help, & she was willing to try anything. Within a day or so the shingles attack subsided. Astragalus is an immunomodulator.
It occurs to me that many here might harbor the varicella zoster virus. & that PCa treatments or stress can reactivate it. All it takes is a weak immune system for it to re-emerge.
Anyway, if PSA goes up don't panic. & if all else fails try astragalus.
-Patrick
ncbi.nlm.nih.gov/pubmed/305...
Clin Case Rep. 2018 Oct 22;6(12):2338-2340. doi: 10.1002/ccr3.1838. eCollection 2018 Dec.
Spurious elevation of Prostate-specific antigen associated with shingles in a prostate cancer patient undergoing active surveillance.
Mesci A1, Liu SK1, Loblaw DA1.
Author information
1
Department of Radiation Oncology, Odette Cancer Institute, Sunnybrook Hospital University of Toronto Ontario Canada.
Abstract
Spurious PSA increase in prostate cancer associated with shingles reactivation should be considered under the right clinical scenario to avoid unnecessary investigations or treatment.
KEYWORDS:
active surveillance; prostate cancer; shingles; spurious PSA elevation
PMID: 30564325 PMCID: PMC6293149 DOI: 10.1002/ccr3.1838